Table 6.
MD Anderson dysphagia inventory (MDADI)
| MDADIa | Group | Baseline data | Effect data | Follow-up minus post-therapy data | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | 25;75b | N | Median | 25;75 | N | P | Median | 25;75 | N | P | ||
| Global assessment | Group TT | 3 | 2;4 | 29 | 0 | 0;2 | 29 | 0.012 | 0 | −1,0 | 17 | N.A. |
| NMES-M | 4 | 2;4 | 29 | 0 | 0;1 | 28 | N.S. | 0 | 0;0 | 13 | ||
| NMES-S | 4 | 2;5 | 27 | 0 | 0;1 | 27 | N.S. | 0 | −1;0 | 13 | ||
| Total group | 4 | 2;4 | 85 | 0 | 0;1 | 84 | 0.000 | 0 | −1;0 | 43 | 0.011 | |
| Functional subscale | Group TT | 21 | 19;22 | 27 | 0 | −2;3 | 25 | N.S. | 0 | −1;3 | 16 | N.A. |
| NMES-M | 21 | 18;22 | 29 | 0 | −2;4 | 27 | N.S. | 0 | −5;0 | 11 | ||
| NMES-S | 20 | 18;24 | 25 | 0 | −1;2 | 25 | N.S. | 1 | −2;2 | 13 | ||
| Total group | 21 | 18;23 | 81 | 0 | −2;4 | 77 | N.S. | 0 | −2;2 | 40 | N.S. | |
| Physical subscale | Group TT | 28 | 24;31 | 28 | 2 | −1;5 | 24 | N.S. | 0 | −5;3 | 15 | N.A. |
| NMES-M | 26 | 22;30 | 29 | 1 | −2,7 | 28 | N.S. | 0 | −3;2 | 13 | ||
| NMES-S | 28 | 22;32 | 25 | 2 | −5;6 | 25 | N.S. | −2 | −5;1 | 12 | ||
| Total group | 28 | 23;30 | 82 | 2 | −1;6 | 77 | 0.000 | −1 | −4;2 | 40 | N.S. | |
| Emotional subscale | Group TT | 21 | 18;24 | 27 | 1 | −3;3 | 27 | N.S. | 0 | −3;2 | 16 | N.A. |
| NMES-M | 21 | 17;24 | 28 | 2 | 0,4 | 26 | N.S. | −1 | −4;2 | 13 | ||
| NMES-S | 20 | 18;24 | 27 | 1 | −1;3 | 26 | N.S. | −2 | −5;2 | 12 | ||
| Total group | 21 | 18;24 | 82 | 1 | −1;3 | 79 | 0.002 | −1 | −3;2 | 41 | N.S. | |
| Total score | Group TT | 72 | 63;80 | 26 | 2 | −4;8 | 22 | N.S. | 1 | −4;6 | 13 | N.A. |
| NMES-M | 69 | 63;81 | 28 | 7 | 2,13 | 25 | 0,007 | −3 | −10;3 | 11 | ||
| NMES-S | 74 | 65;82 | 24 | 4 | −1;9 | 23 | N.S. | −2 | −11;3 | 11 | ||
| Total group | 72 | 64;81 | 78 | 4 | −1;11 | 70 | 0.000 | 0 | −10;3 | 35 | N.S. | |
Descriptive statistics of the baseline data, the effect data (post-minus pretreatment data), and the follow-up minus post-therapy data, the number of patients per treatment group, and the level of significance of the difference between post-therapy data compared to baseline data for all groups as well as the level of significance of the difference between follow-up data compared to post-therapy data for all groups combined
TT traditional therapy; NMES-M neuromuscular electrical stimulation on a motor level; NMES-S neuromuscular electrical stimulation on a sensory level; N.S. not significant; N.A. not applicable
aThe range of the Total Score, the Global Assessment, and the Emotional, Functional, and Physical subscales is, respectively, 20–100, 1–5, 6–30, 5–25, and 8–40
b25th percentile;75th percentile